[The cytokine profile during experimental esophagitis and modification of cytoprotective mechanisms].
The cytokine profile during experimental esophagitis and modification of NO-NOS and prostaglandin activity and the melatonin administration has been investigated.
Zaiachkivs'ka
O S
OS
Hzhehots'kyĭ
M R
MR
Slivovs'kyĭ
Z
Z
Bzhozovs'kyĭ
T
T
Konturek
S Ia
SIa
D000818:Animals; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D016207:Cytokines / Q000276:immunology*; D019610:Cytoprotection / Q000187:drug effects; D004195:Disease Models, Animal; D004941:Esophagitis / Q000276:immunology* / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control; D008297:Male; D008550:Melatonin / Q000008:administration & dosage / Q000627:therapeutic use*; D009569:Nitric Oxide / Q000378:metabolism; D019001:Nitric Oxide Synthase / Q000378:metabolism; D010434:Pepsin A / Q000494:pharmacology; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar; D019323:omega-N-Methylarginine / Q000494:pharmacology
D016861:Cyclooxygenase Inhibitors; D016207:Cytokines; D019323:omega-N-Methylarginine; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase; D011451:Prostaglandin-Endoperoxide Synthases; D010434:Pepsin A; D008550:Melatonin